FF Pharmaceuticals' Series A Round

FF Pharmaceuticals raised a round of funding on January 23, 2013.

FF Pharma will focus on the development of novel disease-modifying therapeutics for the treatment of inflammatory and autoimmune diseases. The company's lead product, FFP102, is a clinical stage human…

Articles about FF Pharmaceuticals' Series A Round: